abagovomab 37
abciximab 34
abituzumab 24
abrilumab 23
actoxumab 21
adalimumab 22
aducanumab 15
afasevikumab 21
alacizumab_pegol 13
alemtuzumab 34
alirocumab 23
amatuximab 47
andecaliximab 25
anifrolumab 24
anrukinzumab 24
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 26
ascrinvacumab 8
atezolizumab 16
atinumab 16
avelumab 15
basiliximab 37
bavituximab 43
begelomab 30
benralizumab 32
bevacizumab_beta 26
bezlotoxumab 21
bimagrumab 22
bleselumab 21
blinatumomab 37
blosozumab 32
bococizumab 21
brazikumab 18
brentuximab_vedotin 38
briakinumab 20
brodalumab 17
brolucizumab 30
brontictuzumab 29
burosumab 23
cabiralizumab 30
camrelizumab 16
canakinumab 27
cantuzumab_ravtansin 51
carlumab 17
carotuximab 30
cergutuzumab_amunaleukin2 30
cergutuzumab_amunaleukin 30
certolizumab_pegol 27
cetiximab 49
citatuzumab_bogatox 30
cixutumumab 29
clivatuzumab_tetraxetan 30
codrituzumab 34
conatumumab 14
concizumab 33
crenezumab 24
crizanlizumab 30
crotedumab 21
dacetuzumab 26
daclizumab 21
dalotuzumab 44
dapirolizumab_pegol 29
daratumumab 14
dectrekumab 11
demcizumab 28
denosumab 10
depatuxizumab 30
depatuxizumab_mafodotin 30
dezamizumab 25
dinutuximab 42
diridavumab 31
domagrozumab 18
drozitumab 20
duligotuzumab 21
durvalumab 13
dusigitumab 24
efalizumab 36
efungumab 31
eldelumab 18
elezanumab 25
elgemtumab 14
elotuzumab 20
emactuzumab 24
emapalumab 28
emibetuzumab 23
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 21
enokizumab 27
enoticumab 20
ensituximab 39
eptinezumab 20
erenumab 23
etaracizumab 18
etrolizumab 25
evinacumab 23
evolocumab 20
farletuzumab 15
fasinumab 27
fezakinumab 26
fibatuzumab 16
ficlatuzumab 26
firivumab 37
flanvotumab 23
fletikumab 29
foralumab 15
foravirumab 16
fremanezumab 31
fresolimumab 19
fulranumab 22
futuximab 35
galcanezumab 23
ganitumab 31
gantenerumab 14
gemetuzumab 36
gemtuzumab2 28
gemtuzumab 31
gevokizumab 29
girentuximab 33
glembatumumab 22
glembatumumab_vedotin 22
guselkumab 24
ibalizumab 30
ibritumomab 43
icrucumab 13
idarucizumab 41
ifabotuzumab 16
imalumab 19
imgatuzumab 25
inclacumab 21
indatuximab_ravtansin 39
indusatumab 23
inebilizumab 31
intetumumab 17
iodine_girentuximab 31
ipilimumab 7
iratumumab 18
isatuximab 41
itolizumab 28
ixekizumab 36
labetuzumab_govitecan 26
lambrolizumab 31
lampalizumab 31
lanadelumab 19
landogrozumab 19
laprituximab 31
lebrikizumab 42
lendalizumab 28
lenzilumab 21
lifastuzumab_vedotin 26
ligelizumab 25
lilotomab 44
lirilumab 25
lodelcizumab 20
lokivetmab 27
lorvotuzumab_mertansin 28
lucatumumab 31
lumretuzumab 22
lupartumab 17
lutikizumab 23
margetuximab 42
milatuzumab 45
mirvetuximab 41
mirvetuximab_soravtansin 41
modotuximab 46
mogamulizumab 36
monalizumab 23
motavizumab 42
moxetumomab_pasudotox 33
namilumab 26
naratuximab 35
naratuximab_emtansin 35
narnatumab 20
navicixizumab2 30
navicixizumab 29
navivumab 41
necitumumab 12
nemolizumab 32
nesvacumab 18
nivolumab 13
obiltoxaximab 25
obinutuzumab 36
ocaratuzumab 29
ofatumumab 20
olaratumab 19
olokizumab 28
omalizumab 22
onartuzumab 25
ontuxizumab 34
opicinumab 15
orticumab 16
otelixizumab 41
oxelumab 13
ozanezumab 37
pamrevlumab 13
panobacumab 31
parsatuzumab 29
pasotuxizumab 23
pateclizumab 21
patritumab 26
pembrolizumab 31
perakizumab 25
pidilizumab 24
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 27
polatuzumab_vedotin 24
ponezumab 40
prezalumab 16
pritoxaximab 44
quilizumab 23
racotumomab 35
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 32
ranibizumab 26
refanezumab 27
remtolumab 21
rilotumumab 22
rinucumab 21
risankizumab 38
rituximab 28
rivabazumab 24
robatumumab 20
roledumab 36
romosozumab 26
rontalizumab 25
rosmantuzumab 31
rozanolixizumab 25
sacituzumab 35
sacituzumab_govitecan 35
samalizumab 29
sapelizumab 25
sarilumab 18
secukinumab 18
seribantumab 18
setoxaximab 51
sifalimumab 14
siltuximab 25
simtuzumab 31
sirukumab 13
solanezumab 27
solitomab 34
stamulumab 20
suptavumab 28
suvizumab 25
tabalumab 16
tadocizumab 22
tamtuvetmab 37
tanezumab 24
tarextumab 13
tavolixizumab 19
telisotuzumab 32
teplizumab 27
tesidolumab 24
tezepelumab 26
tigatuzumab 18
tildrakizumab 24
timolumab 17
tisotumab 16
tosatoxumab 42
tositumomab 40
tralokinumab 30
trastuzumab 24
tregalizumab 25
trevogrumab 15
ublituximab 36
urelumab 27
ustekinumab 30
utomilumab 28
vadastuximab 31
vadastuximab_talirin 31
vandortuzumab_vedotin 22
vantictumab 22
vanucizumab2 26
vanucizumab 31
varlilumab 17
vatelizumab 26
vedolizumab 33
veltuzumab 21
vesencumab 12
vorsetuzumab 25
vorsetuzumab_mafodotin 25
vunakizumab 39
xentuzumab 21
zatuximab 46
